Welcome to LookChem.com Sign In|Join Free

CAS

  • or

137347-01-4

Post Buying Request

137347-01-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

137347-01-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 137347-01-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,7,3,4 and 7 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 137347-01:
(8*1)+(7*3)+(6*7)+(5*3)+(4*4)+(3*7)+(2*0)+(1*1)=124
124 % 10 = 4
So 137347-01-4 is a valid CAS Registry Number.

137347-01-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Bromo-3-Ethoxy-6-Nitropyridine

1.2 Other means of identification

Product number -
Other names 3-ethoxy-2-bromo-6-nitro-pyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:137347-01-4 SDS

137347-01-4Relevant articles and documents

PYRAZOLES USEFUL IN THE TREATMENT OF INFLAMMATION

-

Page/Page column 58, (2008/06/13)

There is provided compounds of formula (I), wherein R1, R2, X1, X2 and n have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a lipoxygenase (e.g. 15-lipoxygenase) is desired and/or required, and particularly in the treatment of inflammation.

Positive allosteric modulators of the nicotinic acetylcholine receptor

-

Page 40, (2010/02/05)

The invention provides compounds of Formula I: These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals used to treat diseases or conditions in which α7 nAChR is known to be involved.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 137347-01-4